Cargando…

RAD51C germline mutations in breast and ovarian cancer patients

Detalles Bibliográficos
Autores principales:	Akbari, Mohammad R, Tonin, Patricia, Foulkes, William D, Ghadirian, Parviz, Tischkowitz, Marc, Narod, Steven A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949649/ https://www.ncbi.nlm.nih.gov/pubmed/20723205 http://dx.doi.org/10.1186/bcr2619

Ejemplares similares

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families
por: Osher, D J, et al.
Publicado: (2012)

Germline TP53 mutational spectrum in French Canadians with breast cancer
por: Arcand, Suzanna L, et al.
Publicado: (2015)

Germline mutation in the RAD51B gene confers predisposition to breast cancer
por: Golmard, Lisa, et al.
Publicado: (2013)

RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families
por: Clague, Jessica, et al.
Publicado: (2011)

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
por: Thompson, ER, et al.
Publicado: (2012)

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D
por: Yang, Xin, et al.
Publicado: (2020)

Mutation screening of RAD51C in male breast cancer patients
por: Silvestri, Valentina, et al.
Publicado: (2011)

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
por: Foulkes, William D, et al.
Publicado: (2007)

Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations
por: Yao, Hongwen, et al.
Publicado: (2022)

Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination
por: Setton, Jeremy, et al.
Publicado: (2021)

The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population
por: Alenezi, Wejdan M., et al.
Publicado: (2022)

Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families
por: Oros, Kathleen K, et al.
Publicado: (2006)

Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent
por: Tischkowitz, Marc, et al.
Publicado: (2013)

Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women
por: Novak, David J, et al.
Publicado: (2008)

Clinical implications of germline mutations in breast cancer: TP53
por: Schon, Katherine, et al.
Publicado: (2017)

RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families
por: Schnurbein, Gioia, et al.
Publicado: (2013)

UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2
por: Hanson, Helen, et al.
Publicado: (2023)

Clinical implications of germline mutations in breast cancer genes: RECQL
por: Bowden, A. Ramsay, et al.
Publicado: (2019)

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
por: Metcalfe, Kelly, et al.
Publicado: (2014)

Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic
por: Janatova, Marketa, et al.
Publicado: (2015)

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2005)

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
por: Cruz, C, et al.
Publicado: (2018)

Weight History, Smoking, Physical Activity and Breast Cancer Risk among French-Canadian Women Non-Carriers of More Frequent BRCA1/2 Mutations
por: Bissonauth, Vishnee, et al.
Publicado: (2009)

Roles of XRCC2, RAD51B and RAD51D in RAD51-Independent SSA Recombination
por: Serra, Heïdi, et al.
Publicado: (2013)

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
por: Metcalfe, Kelly A, et al.
Publicado: (2005)

Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction
por: Subramanyam, Shyamal, et al.
Publicado: (2013)

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
por: Łukomska, Alicja, et al.
Publicado: (2021)

Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor
por: Greenhough, Luke A., et al.
Publicado: (2023)

Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation
por: Sullivan, Meghan R., et al.
Publicado: (2021)

Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing
por: Cummings, Shelly, et al.
Publicado: (2021)

Analysis of RAD51D in Ovarian Cancer Patients and Families with a History of Ovarian or Breast Cancer
por: Thompson, Ella R., et al.
Publicado: (2013)

RAD51B in Familial Breast Cancer
por: Pelttari, Liisa M., et al.
Publicado: (2016)

Homologous Pairing Activities of Two Rice RAD51 Proteins, RAD51A1 and RAD51A2
por: Morozumi, Yuichi, et al.
Publicado: (2013)

Rad51 paralogs Rad55-Rad57 balance the anti-recombinase Srs2 in Rad51 filament formation
por: Liu, Jie, et al.
Publicado: (2011)

Polymorphisms in RAD51 and their relation with breast cancer in Saudi females
por: Tulbah, Sahar, et al.
Publicado: (2016)

RAD51 as a biomarker for homologous recombination deficiency in high‐grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test
por: Kramer, Claire JH, et al.
Publicado: (2023)

RAD51AP1 mediates RAD51 activity through nucleosome interaction
por: Pires, Elena, et al.
Publicado: (2021)

Hot on RAD51C: structure and functions of RAD51C‐XRCC3
por: Szakal, Barnabas, et al.
Publicado: (2023)

BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases
por: Suszynska, Malwina, et al.
Publicado: (2020)

Variation in the RAD51 gene and familial breast cancer
por: Lose, Felicity, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_aokigaf9bjmhrstq55s8uf6tdg